Skip to main content
Institute for Global Health & Infectious Diseases

2017

 

  1. Han L, Hudgens MG, Emch ME, et al. RTS,S/AS01 Malaria Vaccine Efficacy is Not Modified by Seasonal Precipitation: Results from a Phase 3 Randomized Controlled Trial in Malawi. Scientific reports 2017; 7(1): 7200.
  2. Tenforde MW, Yadav A, Dowdy DW, et al. Vitamin A and D Deficiencies Associated With Incident Tuberculosis in HIV-Infected Patients Initiating Antiretroviral Therapy in Multinational Case-Cohort Study. J Acquir Immune Defic Syndr 2017; 75(3): e71-e9.
  3. Escamilla V, Alker A, Dandalo L, et al. Effects of community-level bed net coverage on malaria morbidity in Lilongwe, Malawi. Malar J 2017; 16(1): 142.
  4. Sanyahumbi AS, Hosseinipour M, Guffey D, et al. HIV Infected Children in Malawi have Decreased Performance on the 6 Minute Walk Test with Preserved Cardiac Mechanics Regardless of Antiretroviral Treatment Status. Pediatr Infect Dis J 2017.
  5. Kourtis AP, Haddad L, Tang J, et al. A randomized clinical trial on the effects of progestin contraception in the genital tract of HIV-infected and uninfected women in Lilongwe, Malawi: Addressing evolving research priorities. Contemp Clin Trials 2017; 52: 27-34.
  6. Chagomerana MB, Tomlinson J, Young S, Hosseinipour MC, Banza L, Lee CN. High morbidity and mortality after lower extremity injuries in Malawi: A prospective cohort study of 905 patients. Int J Surg 2017; 39: 23-9.
  7. Kopp DM, Rosenberg NE, Stuart GS, et al. Patterns of Contraceptive Adoption, Continuation, and Switching after Delivery among Malawian Women. PLoS One 2017; 12(1): e0170284.
  8. Rees CA, Flick RJ, Sullivan D, et al. An Analysis of the Last Clinical Encounter before Outpatient Mortality among Children with HIV Infection and Exposure in Lilongwe, Malawi. PLoS One 2017; 12(1): e0169057.
  9. Cataldo F, Chiwaula L, Nkhata M, et al. Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi. J Acquir Immune Defic Syndr 2017; 74(5): 517-22.
  10. Chagomerana MB, Miller WC, Pence BW, et al. PMTCT Option B+ Does Not Increase Preterm Birth Risk and May Prevent Extreme Prematurity: A Retrospective Cohort Study in Malawi. J Acquir Immune Defic Syndr 2017; 74(4): 367-74.
  11. Kohler RE, Tomlinson J, Chilunjika TE, Young S, Hosseinipour M, Lee CN. “Life is at a standstill” Quality of life after lower extremity trauma in Malawi. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation 2017; 26(4): 1027-35.
  12. Lancaster KE, Lungu T, Mmodzi P, et al. The association between substance use and sub-optimal HIV treatment engagement among HIV-infected female sex workers in Lilongwe, Malawi. AIDS Care 2017; 29(2): 197-203.
  13. Wesevich A, Mtande T, Saidi F, et al. Role of male partner involvement in ART retention and adherence in Malawi’s Option B+ program. AIDS Care 2017: 1-9.
  14. Croffut SE, Hamela G, Mofolo I, et al. HIV-positive Malawian women with young children prefer overweight body sizes and link underweight body size with inability to exclusively breastfeed. Matern Child Nutr 2017.
  15. Eshleman SH, Wilson EA, Zhang XC, et al. Virologic outcomes in early antiretroviral treatment: HPTN 052. HIV Clin Trials 2017: 1-10.
  16. Chiwaula LS, Chirwa GC, Cataldo F, et al. Erratum to: The value of informal care in the context of option B+ in Malawi: a contingent valuation approach. BMC Health Serv Res 2017; 17(1): 191.
  17. Rosenberg NE, Graybill LA, Wesevich A, et al. The Impact of Couple HIV Testing and Counseling on Consistent Condom Use among Pregnant Women and their Male Partners: An Observational Study. J Acquir Immune Defic Syndr 2017.
  18. Flax VL, Hamela G, Mofolo I, Hosseinipour MC, Hoffman IF, Maman S. Factors influencing postnatal Option B+ participation and breastfeeding duration among HIV-positive women in Lilongwe District, Malawi: A qualitative study. PLoS One 2017; 12(4): e0175590.
  19. Lemani C, Tang JH, Kopp D, et al. Contraceptive uptake after training community health workers in couples counseling: A cluster randomized trial. PLoS One 2017; 12(4): e0175879.
  20. Singh K, Speizer I, Kim ET, Lemani C, Phoya A. Reaching vulnerable women through maternity waiting homes in Malawi. Int J Gynaecol Obstet 2017; 136(1): 91-7.
  21. Westmoreland KD, Stanley CC, Montgomery ND, et al. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer 2017; 64(5).
  22. Palumbo PJ, Wilson EA, Piwowar-Manning E, et al. Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052. PLoS One 2017; 12(5): e0177281.
  23. Fogel JM, Piwowar-Manning E, Debevec B, et al. Impact of early antiretroviral therapy on the performance of HIV rapid tests and HIV incidence assays. J Acquir Immune Defic Syndr 2017.
  24. Celum C, Hong T, Cent A, et al. Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study. J Infect Dis 2017; 215(6): 907-10.
  25. Chiwaula LS, Chirwa GC, Cataldo F, et al. Erratum to: The value of informal care in the context of option B+ in Malawi: a contingent valuation approach. BMC Health Serv Res 2017; 17(1): 191.
  26. van Lettow M, Tweya H, Rosenberg NE, et al. Baseline characteristics of study sites and women enrolled in a three-arm cluster randomized controlled trial: PMTCT uptake and retention (pure) Malawi. Reprod Health 2017; 14(1): 82.
  27. Hosseinipour M, Nelson JAE, Trapence C, et al. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi’s Option B+ Program: Results From the PURE Malawi Study. J Acquir Immune Defic Syndr 2017; 75 Suppl 2: S149-S55.
  28. Ongubo DM, Lim R, Tweya H, et al. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi. BMC Infect Dis 2017; 17(1): 461.
  29. Phiri S, Tweya H, van Lettow M, et al. Impact of Facility- and Community-Based Peer Support Models on Maternal Uptake and Retention in Malawi’s Option B+ HIV Prevention of Mother-to-Child Transmission Program: A 3-Arm Cluster Randomized Controlled Trial (PURE Malawi). J Acquir Immune Defic Syndr 2017; 75 Suppl 2: S140-S8.
  30. Hauser BM, Miller WC, Tweya H, et al. Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi. Int J STD AIDS 2017: 956462417721658.
  31. Greer AE, Ou SS, Wilson E, et al. A Comparison of Hepatitis B Virus Infection in HIV-infected and HIV-uninfected Participants Enrolled in a Multi-National Clinical Trial: HPTN 052. J Acquir Immune Defic Syndr 2017.
  32. Bisson GP, Ramchandani R, Miyahara S, et al. Risk factors for early mortality on antiretroviral therapy in advanced HIV-infected adults. AIDS 2017.
  33. Eshleman SH, Hudelson SE, Redd AD, et al. Treatment as Prevention: Characterization of Partner Infections in the HIV Prevention Trials Network 052 Trial. J Acquir Immune Defic Syndr 2017; 74(1): 112-6.
  34. Chintalapudi N, Hamela G, Mofolo I, et al. Infant and Young Child Feeding Decision Making and Practices: Malawian Mothers’ and Fathers’ Roles in the Context of HIV. J Hum Lact 2017: 890334417719245.
  35. Kopp DM, Tang JH, Stuart GS, et al. Dual Method Use among Postpartum HIV-Infected and HIV-Uninfected Malawian Women: A Prospective Cohort Study. Infect Dis Obstet Gynecol 2017; 2017: 1475813.
  36. Rosenberg NE, Gross R, Mtande T, et al. “We have heard it together”: a qualitative analysis of couple HIV testing and counselling recruitment in Malawi’s Option B+ programme. African journal of AIDS research : AJAR 2017; 16(3): 215-23.
  37. Moses A, Mwafongo A, Chikasema M, et al. Risk factors for common cancers among patients at Kamuzu Central Hospital in Lilongwe, Malawi: A retrospective cohort study. Malawi Med J 2017; 29(2): 136-41.
  38. Rosenberg NE, Graybill LA, Wesevich A, et al. Individual, Partner, and Couple Predictors of HIV Infection among Pregnant Women in Malawi: A Case-Control Study. AIDS Behav 2017.
  39. Lancaster KE, MacLean SA, Lungu T, et al. Socioecological Factors Related to Hazardous Alcohol use Among Female Sex Workers in Lilongwe, Malawi: A Mixed Methods Study. Subst Use Misuse 2017: 1-10.
  40. Price JT, Rosenberg NE, Vansia D, et al. Predictors of HIV, HIV Risk Perception, and HIV Worry among Adolescent Girls and Young Women in Lilongwe, Malawi. J Acquir Immune Defic Syndr 2017.
  41. Ewing AC, King CC, Wiener JB, et al. Effects of concurrent exposure to antiretrovirals and cotrimoxazole prophylaxis among HIV-exposed, uninfected infants. AIDS 2017; 31(18): 2455-63.
  42. Smith AG, Eckerle M, Mvalo T, et al. CPAP IMPACT: a protocol for a randomised trial of bubble continuous positive airway pressure versus standard care for high-risk children with severe pneumonia using adaptive design methods. BMJ open respiratory research 2017; 4(1): e000195.
  43. Chikaonda T, Nguluwe N, Barnett B, et al. Performance of Xpert((R)) MTB/RIF among tuberculosis outpatients in Lilongwe, Malawi. African journal of laboratory medicine 2017; 6(2): 464.
  44. Chikaonda T, Ketseoglou I, Nguluwe N, et al. Molecular characterisation of rifampicin-resistant Mycobacterium tuberculosis strains from Malawi. African journal of laboratory medicine 2017; 6(2): 463.
  45. Hobbs CV, Gabriel EE, Kamthunzi P, et al. Prevalence of Asymptomatic Parasitemia and Gametocytemia in HIV-Infected Children on Differing Antiretroviral Therapy. Am J Trop Med Hyg 2017.
  46. Boivin MJ, Barlow-Mosha L, Chernoff M, et al. Neuropsychological performance in African children with HIV enrolled in a multi-site anti-retroviral clinical trial. AIDS 2017.
  47. Huang L, Carey V, Lindsey JC, et al. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children. PLoS One 2017; 12(10): e0186589.
  48. Murphy G, McCormack V, Abedi-Ardekani B, et al. International cancer seminars: a focus on esophageal squamous cell carcinoma. Ann Oncol 2017; 28(9): 2086-93.
  49. Kaimila B, van der Gronde T, Stanley C, et al. Salvage chemotherapy for adults with relapsed or refractory lymphoma in Malawi. Infect Agent Cancer 2017; 12: 45.
  50. Kaimila B, van der Gronde T, Kasonkanji E, et al. Short Communication: CD4 Count and HIV RNA Trends for HIV-Associated Lymphoproliferative Disorders in Malawi. AIDS Res Hum Retroviruses 2017; 33(10): 1045-7.
  51. Kasonkanji E, Kaimila B, Amuquandoh A, et al. Successful Treatment of Classical Hodgkin Lymphoma During Pregnancy in Malawi. Journal of oncology practice / American Society of Clinical Oncology 2017; 13(5): 338-40.
  52. Host KM, Horner MJ, van der Gronde T, et al. Kaposi’s sarcoma in Malawi: a continued problem for HIV-positive and HIV-negative individuals. AIDS 2017; 31(2): 318-9.
  53. Kohler RE, Miller AR, Gutnik L, Lee CN, Gopal S. Experiences and perceptions regarding clinical breast exam screening by trained laywomen in Malawi. Cancer Causes Control 2017; 28(2): 137-43.
  54. Kohler RE, Gopal S, Miller AR, et al. A framework for improving early detection of breast cancer in sub-Saharan Africa: A qualitative study of help-seeking behaviors among Malawian women. Patient Educ Couns 2017; 100(1): 167-73.
  55. Chinula L, Moses A, Gopal S. HIV-associated malignancies in sub-Saharan Africa: progress, challenges, and opportunities. Curr Opin HIV AIDS 2017; 12(1): 89-95.
  56. Liu W, Snell JM, Jeck WR, et al. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. JCI insight 2017; 2(22).
  57. Kohler RE, Gopal S, Lee CN, Weiner BJ, Reeve BB, Wheeler SB. Breast Cancer Knowledge, Behaviors, and Preferences in Malawi: Implications for Early Detection Interventions From a Discrete Choice Experiment. Journal of global oncology 2017; 3(5): 480-9.
  58. Gopal S. Global Health: What’s in It for Us? JAMA 2017; 318(14): 1325-6.
  59. Stanley CC, van der Gronde T, Westmoreland KD, et al. Risk factors and reasons for treatment abandonment among children with lymphoma in Malawi. Support Care Cancer 2017.
  60. Faggons CE, Mabedi CE, Liomba NG, et al. Human papillomavirus in head and neck squamous cell carcinoma: A descriptive study of histologically confirmed cases at Kamuzu Central Hospital in Lilongwe, Malawi. Malawi Med J 2017; 29(2): 142-5.
  61. Tomoka T, Powers E, van der Gronde T, et al. Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases. BMC Cancer 2017; 17(1): 633.
  62. Westmoreland KD, El-Mallawany NK, Kazembe P, Stanley CC, Gopal S. Dissecting heterogeneous outcomes for paediatric Burkitt lymphoma in Malawi after anthracycline-based treatment. Br J Haematol 2017.
  63. Gopal S. Cancer trials in sub-Saharan Africa: Aligning research and care. PLoS Med 2017; 14(7): e1002351.
  64. El-Mallawany NK, Mutai M, Mtete I, et al. Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, Malawi. Global pediatric health 2017; 4: 2333794X17715831.
  65. Westmoreland KD, Montgomery ND, Stanley CC, et al. Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi. Int J Cancer 2017; 140(11): 2509-16.
  66. Prin M, Eaton J, Mtalimanja O, Charles A. High Elective Surgery Cancellation Rate in Malawi Primarily Due to Infrastructural Limitations. World J Surg 2017.
  67. Grudziak J, Snock C, Zalinga T, et al. Pre-burn malnutrition increases operative mortality in burn patients who undergo early excision and grafting in a sub-Saharan African burn unit. Burns : journal of the International Society for Burn Injuries 2017.
  68. Charles AG, Mock C. Advancing Global Surgery: Moving Beyond Identifying Problems to Finding Solutions. World J Surg 2017; 41(12): 2979-80.
  69. Eaton J, Hanif AB, Mzumara S, Charles A. The Utility of Local Anesthesia for Neurosurgical Interventions in a Low-Resource Setting: A Case Series. World J Surg 2017.
  70. Grudziak J, Gallaher J, Banza L, et al. The Effect of a Surgery Residency Program and Enhanced Educational Activities on Trauma Mortality in Sub-Saharan Africa. World J Surg 2017; 41(12): 3031-7.
  71. Shah M, Gallaher J, Msiska N, McLean SE, Charles AG. Colostomy as a Bridge to Definitive Pediatric Surgical Care: A Sub-Saharan African Experience. Am Surg 2017; 83(9): 367-9.
  72. Purcell L, Mabedi CE, Gallaher J, et al. Variations in injury characteristics among paediatric patients following trauma: A retrospective descriptive analysis comparing pre-hospital and in-hospital deaths at Kamuzu Central Hospital, Lilongwe, Malawi. Malawi Med J 2017; 29(2): 146-50.
  73. Eaton J, Hanif AB, Grudziak J, Charles A. Epidemiology, Management, and Functional Outcomes of Traumatic Brain Injury in Sub-Saharan Africa. World neurosurgery 2017; 108: 650-5.
  74. Haac BE, Gallaher JR, Mabedi C, Geyer AJ, Charles AG. Task Shifting: The Use of Laypersons for Acquisition of Vital Signs Data for Clinical Decision Making in the Emergency Room Following Traumatic Injury. World J Surg 2017; 41(12): 3066-73.
  75. Eaton J, Hanif AB, Mulima G, Kajombo C, Charles A. Outcomes Following Exploratory Burr Holes for Traumatic Brain Injury in a Resource Poor Setting. World neurosurgery 2017; 105: 257-64.
  76. Charles AG, Gallaher J, Cairns BA. Burn Care in Low- and Middle-Income Countries. Clinics in plastic surgery 2017; 44(3): 479-83.
  77. Eaton J, Grudziak J, Hanif AB, Chisenga WC, Hadar E, Charles A. The effect of anatomic location of injury on mortality risk in a resource-poor setting. Injury 2017; 48(7): 1432-8.
  78. Grudziak J, Snock C, Mjuweni S, Gallaher J, Cairns B, Charles A. The effect of pre-existing malnutrition on pediatric burn mortality in a sub-Saharan African burn unit. Burns : journal of the International Society for Burn Injuries 2017; 43(7): 1486-92.
  79. Tyson AF, Gallaher J, Mjuweni S, Cairns BA, Charles AG. The effect of seasonality on burn incidence, severity and outcome in Central Malawi. Burns : journal of the International Society for Burn Injuries 2017; 43(5): 1078-82.
  80. Gallaher JR, Mulima G, Kopp D, Shores CG, Charles AG. Consequences of centralised blood bank policies in sub-Saharan Africa. The Lancet Global health 2017; 5(2): e131-e2.
  81. Gallaher JR, Cairns B, Varela C, Charles AG. Mortality After Peritonitis in Sub-Saharan Africa: An Issue of Access to Care. JAMA surgery 2017; 152(4): 408-10.
  82. Kopp DM, Wilkinson J, Bengtson A, et al. Fertility outcomes following obstetric fistula repair: a prospective cohort study. Reprod Health 2017; 14(1): 159.
  83. Kopp DM, Bengtson A, Wilkinson J, Chipungu E, Moyo M, Tang JH. Contraceptive knowledge, use and intentions of Malawian women undergoing obstetric fistula repair. The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 2017; 22(5): 375-80.
  84. Kopp DM, Bengtson AM, Tang JH, Chipungu E, Moyo M, Wilkinson J. Authors’ reply re: Use of a postoperative pad test to identify continence status in women after obstetric vesicovaginal fistula repair: a prospective cohort study. BJOG 2017; 124(10): 1623.
  85. Kopp DM, Bengtson AM, Tang JH, Chipungu E, Moyo M, Wilkinson J. Use of a postoperative pad test to identify continence status in women after obstetric vesicovaginal fistula repair: a prospective cohort study. BJOG 2017; 124(6): 966-72.
  86. McCollum ED, Smith AG, Eckerle M, Mvalo T, O’Brien KL, Baqui AH. CPAP treatment for children with pneumonia in low-resource settings. The lancet Respiratory medicine 2017; 5(12): 924-5.
  87. Eckerle M, Crouse HL, Chiume M, et al. Building Sustainable Partnerships to Strengthen Pediatric Capacity at a Government Hospital in Malawi. Frontiers in public health 2017; 5: 183.
  88. Drakeley C, Abdulla S, Agnandji ST, et al. Longitudinal estimation of Plasmodium falciparum prevalence in relation to malaria prevention measures in six sub-Saharan African countries. Malar J 2017; 16(1): 433.
  89. Zadrozny S, Westreich D, Hudgens MG, et al. Effect of Postnatal HIV Treatment on Clinical Mastitis and Breast Inflammation in HIV-Infected Breast-feeding Women. Paediatric and perinatal epidemiology 2017; 31(2): 134-43.
  90. Williams LD, Ofek G, Schatzle S, et al. Potent and broad HIV-neutralizing antibodies in memory B cells and plasma. Science immunology 2017; 2(7).
  91. Bonsignori M, Kreider EF, Fera D, et al. Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. Sci Transl Med 2017; 9(381).
  92. Flick RJ, Munthali A, Simon K, et al. Assessing infection control practices to protect health care workers and patients in Malawi from nosocomial transmission of Mycobacterium tuberculosis. PLoS One 2017; 12(12): e0189140.
  93. Molloy SF, Chiller T, Greene GS, et al. Cryptococcal meningitis: A neglected NTD? PLoS Negl Trop Dis 2017; 11(6): e0005575.
  94. Rosenberg NE, Pettifor AE, Myers L, Phanga T, Marcus R, Bhushan N, Madlingozi N, Vansia D, Masters A, Maseko B, Mtwisha L, Kachigamba A, Tang J, Hosseinipour MC, Bekker LG “Comparing Four Service Delivery Models for Adolescent Girls and Young Women through the ‘Girl Power’ study: Protocol for a Multisite Quasi-experimental Cohort Study” BMJ Open 2017;7:e018480. doi:10.1136/ bmjopen-2017-018480